Kuwaiti Leadership Congratulates Custodian of Two Holy Mosque on Being Discharged from Hospital    Jeddah Jungle Welcomes Visitors with Thrilling Safari Experiences    Nine Zones of Jeddah 2022 Season Welcome Visitors with Worldwide Experiences, Entertainment Shows    Saudi Stock Exchange Main Index Ends Trading Lower at 12,689.87 Points    Riyadh to Host First Conference of International Association for Energy Economics in Middle East    DGDA, Riyadh Third Health Cluster Sign MoU to Provide Healthcare Services in Diriyah    Egypt to Host 2022 Annual Meetings of Islamic Development Bank Group in Sharm El Sheikh    KSrelief Distributes 3,121 Food Baskets to 18,726 Individuals in Hargeisa, Somaliland    Ruler of Ajman Congratulates Custodian of Two Holy Mosques on Being Discharged from Hospital    Saudi delegation concludes partnerships with US capacity building companies    US in Jeddah: 80 years of shared history and strong partnership    Foreign direct investment in Saudi Arabia to jump 20 times by 2030: Al-Falih KSA develops business environment through massive reforms    Sri Lanka down to last day of petrol, warns new PM    Pakistan hit by deadly cholera outbreak as heatwave grips South Asia    Christian leaders condemn Israeli violence at reporter's funeral    How cricket-crazy India scripted world badminton glory    Asian Shares Advance    Heavy Rains Trigger Floods in Northeast India, Killing 8    Elisabeth Borne appointed as new French PM    Twitter boss hits back on Musk doubts over fake accounts    Saudi Telecommunications Delegation Concludes Partnerships with US Pioneering Companies on Capacity Development and Digital Skills, Enhancement of Innovation and Entrepreneurship    Abdulghani clinches first gold for Saudi Arabia in Gulf Games    Guinea-Bissau supports Saudi Arabia's bid to host World Expo 2030    Crown Prince offers condolences to UAE leaders    Saudi Arabia refutes misinformation on NEOM, affirms sovereignty over city    Jazan Hosts West Asian Beach Soccer Championship    Gulf Health Council: Large sunglasses give better UVA protection    Yemeni conjoined twins separated in 15-hour surgery at Riyadh hospital    Former Australia cricketer Symonds dies aged 46 in car crash    China gives up 2023 Asian Cup hosting right    Saudi citizen turns attention to sports after retirement    Lhakpa Sherpa: Woman climbs Everest for record tenth time    5 Arab women filmmakers receive Netflix grant    Over 250 Saudi Female and Male Players to Participate in Kuwait 3rd GCC Games on Friday    Saudi Deaf Athletics Team Leaves for Brazil    Bollywood actor's tweet reignited debate over Hindi as India's national language    SFDA Advises to Wash Dates Well Before Eating    SFDA Advises Against Mixing Surplus of Iftar and Suhoor with Different Foods or Surplus from Other Days    Ministry calls on imams to avoid long supplications in Tahajjud Prayer    Nothing wrong with a Muslim celebrating birthdays, says Saudi scholar    Ranbir Kapoor and Alia Bhatt: Bollywood wishes for star couple on wedding    SFDA Warns Against Microbes Accumulation on Coffee when Stored Incorrectly    SFDA: Over-roasting or roasting is not an indication of the level of food and may cause harm to human health    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    Saudi Arabia Beats Australia to Secure Place in World Cup Finals in Qatar    Pilgrims Perform Dhuhr and Asr Prayers at Arafat Holy Site    Council of Senior Scholars: Muslim Brothers' Group Don't Represent Method of Islam, rather only Follows its Partisan Objectives, Violating our Graceful Religion    Eid Al-Adha Prayer Performed at the Grand Holy Mosque    

Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.

COVID-19 vaccines, sprinting for solutions
Published in The Saudi Gazette on 28 - 05 - 2020

GENEVA — The public health battle against COVID-19 may be in its early phases. More than two months after lockdowns began across Europe, it is clear that there will be no return to the full normality that we knew. Last week, the World Health Organization reported a new daily record in global infections.
On May 13, the WHO said that the virus may simply become endemic, and "never go away," like HIV, malaria or measles. The fastest vaccine developments include Ebola and mumps, which took one and four years respectively to reach the sick.
A vaccine against the Ebola virus moved from safety trials to an experimental version in less than a year and has helped to control two outbreaks since 2014.
Existing vaccines for the SARS (Severe Acute Respiratory Syndrome) and MERS (Middle-East Respiratory Syndrome) coronaviruses were never licensed, and it is possible that exposure to SARS-CoV-2, which causes COVID-19, may not create immunity over time as survivors appear to generate few antibodies. Other viruses, such as influenza, are able to mutate so rapidly that a new vaccine is needed each year.
Innovation and technological advances accelerated during the global conflicts of the twentieth century, and the development of a vaccine for COVID-19 is moving faster than typical drug developments as more resources are mobilised across the world. However, many unknowns remain.
How soon?
The timelines for vaccine development are full of unknowns. In ordinary circumstances, the process may take a decade or more. Furthermore, the timelines depend on whether they refer to a first effective vaccine, the first vaccine for emergency experimental use, the first licenced vaccine, or the first mass-manufactured doseage. Distribution and affordability, already discussed in national and political terms, then become an issue.
And time is of the essence. The speed at which the world's economies can fully re-open largely depends on how quickly a vaccine is available. Scores of research teams are developing treatments, including a collaboration between GSK and Sanofi, two of the world's largest vaccine manufacturers. The two firms hope to begin clinical trials in the second half of this year, making "hundreds of millions of doses" available by the end of 2021. The more global that eventual distribution can be, the better the public health result.
A limited trial by Moderna, Inc. in the US reported last week that its tests showed an immune response from a phase I trial, without serious side-effects. The firm hopes to begin a phase III trial in July. The Moderna vaccine work is a more experimental ‘messenger RNA' development, a technology which has not yet been approved for human use.
A better toolkit
We have consistently argued that an effective response and containment of the virus depends on three elements: the public health response to prevent the pandemic from overrunning medical capacity, monetary input to keep markets function and fiscal stimulus to compensate companies and consumers for job losses and allow a quick economic recovery.
In the absence of a vaccine, the world has improved its tools for coping with the crisis, from greater hospital capacity, social distancing measures and adapting the logistics needed to keep food deliveries moving. It has even started to resolve the production bottlenecks and supplies of medical protective equipment.
This may allow us to consider managing any second wave of outbreaks using the "hammer and dance" approach of local containments that has proven successful in Singapore and South Korea. In short, the world is better placed to manage any second wave, even without a vaccine, than just two months ago.
Many challenges remain, medical, financial and structural. The crisis has underlined inequalities and the precarious existence of many, including those suffering from hunger as a direct consequence of losing paid work, and lacking a social safety net, even in some wealthy nations.
Lacking wisdom
Historian and philosopher Yuval Noah Harari argues that humanity can defeat the pandemic because pathogens operate through "blind mutations," whereas science advances through data. However, said Professor Harari in a recent interview, "we have the power to stop this, but so far we lack the necessary wisdom."
A lack of leadership and unwillingness to cooperate, he has argued, is combining with political assaults on trust in the media, science and expertise generally, undermining the case for international response.
The COVID-19 crisis continues to be as much about the political response as public health challenges. A range of government responses have been on display. Historians of the crisis will judge some of them harshly.
US President Donald Trump has regularly blamed China for the outbreak and repeated theories that are not backed by his own intelligence services. Still, he is not the only leader trying to avoid responsibility for managing the pandemic.
China is reported to have retaliated against an Australian govenrment inquiry into the origins of the outbreak with import bans on Australian coal, barley and beef.
Since viruses don't respect national borders, better healthcare should be a universal priority, not a national one. As long as a virus is circulating, it may mutate into something more dangerous and infect, or re-infect, populations.
On May 20, the WHO's annual health assembly agreed a road map for international cooperation in research, intellectual property and the distribution of an eventual vaccine. That requires an overhaul of the way we think about the public health challenge, and how it is funded.
The US warned that it is suspending its funding to the WHO, which may hurt international support for more vulnerable nations. "Health is not a cost," said WHO Director-General Dr Tedros Adhanom Ghebreyesus, "it's an investment."
This investment need is global. Once the pandemic's worst effects are behind us, we expect to see growth in health care equities, which along with information technology, dominate US indices. For this reason, we have increased our exposure to US equity markets, and reduced our exposure to European stocks.
— The writer is chief investment officer, Lombard Odier Private Bank

Clic here to read the story from its source.